Persistence of immunogenic pulmonary metastases in the presence of protective anti-melanoma immunity

Cancer Research

Volumn 61, Issue 1, 2001, Pages 215-221

  Donawho, C K ^a   Pride, M W ^a   Kripke, M L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL DESTRUCTION; CANCER TRANSPLANTATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; IMMUNOGENICITY; LUNG METASTASIS; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPPRESSOR CELL; TUMOR ESCAPE; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, NEOPLASM; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; HYPERSENSITIVITY, DELAYED; IMMUNITY, NATURAL; IMMUNIZATION; LUNG NEOPLASMS; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0035135082     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Immunologic evaluation of spontaneous regression of an intraocular murine melanoma
2. Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma
3. Model predicting survival in stage 1 melanoma based on tumor progression
4. Autologous hapten-modified melanoma vaccine as postsurgical adjuvant treatment after resection of nodal metastases
5. Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine
6. Vaccination of melanoma patients with peptide- or tumor lysatepulsed dendritic cells
7. Tumor antigens recognized by T lymphocytes
8. Heterogeneity of cytokine production by human malignant melanoma cells
9. Production of multiple cytokines by cultured human melanomas
10. Production of IL-10 by melanoma cells: Examination of its role in immunosuppression mediated by melanoma
11. Differential expression of transforming growth factor beta 1 and interleukin 10 in progression and regressing areas of primary melanoma
12. Hybrid cell vaccination for cancer immune therapy: First clinical trial with metastatic melanoma
13. A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire
14. Enhancement of complement-dependent cytotoxicity by polyvalent melanoma cell vaccine (Cancer-Vax): Correlation with survival
15. Systemic adjuvant treatment of high-risk melanoma: The role of interferon α2b and other immunotherapies (Review)
16. Brain metastasis after immunotherapy in patients with metastatic melanoma or renal cell cancer: Is craniotomy indicated?
17. Improved survival in stage III melanoma patients with GM2 antibodies: A randomized trial of adjuvant vaccination with GM2 ganglioside
18. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells
19. Human cytotoxic T-cells suppress the growth of spontaneous melanoma metastases in SCID/hu mice
20. The biology of melanoma brain metastasis
21. The case for radiosurgery
22. Influence of immune status on the metastasis of three murine fibrosarcomas of different immunogenicities
23. Stepwise immunological selection of antigenic variants during tumor growth
24. Temporal progression of metastasis in lung: Cell survival, dormancy, and location dependence of metastatic inefficiency
25. Biology of metastatic disease
26. Critical determinants of cancer metastasis: Rationale for therapy
27. Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin
28. Latency, histology, and antigenicity of tumors induced by ultraviolet light in three inbred mouse strains
29. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured itt vitro and in vivo
30. Resistance to lysis by cytotoxic T cells. A dominant effect in metastatic mouse prostate cancer cells
31. Differential increase of Fas ligand expression on metastatic and thin or thick primary melanoma cells compared with interleukin-10
32. MHC antigens and cancer: Implications for T-cell surveillance
33. Distribution of autologous tumor-specific cytotoxic T lymphocytes in human metastatic melanoma
34. Orthotopic implantation is essential for the selection, growth and metastasis of human renal cell cancer in nude mice
35. A prospective study of immune responsiveness in human melanoma. I. Assessment of initial pretreatment status with stage of disease
36. Effects of operation on immune response in cancer patients: Sequential evaluation of in vitro lymphocyte function
37. Immunologic reactivity in patients with nasopharyngeal carcinoma. Otolaryngol
38. SALT. Skin-associated lymphoid tissues
39. Negative regulation of inflammation by Fas ligand expression on the vascular endothelium. Trends Cardiovasc
40. Is extravasation a Fas-regulated process?
41. Cyclosporine downregulates Fas ligand expression on vascular endothelial cells: Implication for accelerated vasculopathy by immunosuppressive therapy
42. Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of cancer metastasis
43. Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma ceils to doxorobicin and 5-fluorouracil
44. Modulation of doxorubicin sensitivity and level of P-glycoprotein expression in human colon carcinoma ceils by ectopic and orthotopic environments in nude mice